Our organs, tissues, and vessels are soft. But today's catheters are stiff and straight. For decades, this has restricted access and forced complicated workarounds in endovascular interventions. Until now. Our Transforming Fixation (TFX) technology rewrites the rules. TFX allows catheters to shift from flexible to firm in milliseconds, giving physicians true stability and control while protecting the cardiovascular anatomy — unlocking powerful opportunities to redefine therapies and improve the lives of millions of patients. Less mess. Less stress. With TFX, today’s challenges are history. Jupiter Endovascular is a medical technology startup based in the San Francisco Bay Area, led by a team of successful medical device entrepreneurs. We have big ambitions, with a culture built on innovation, teamwork, and speed.
| Website | https://jupiterendo.com |
| Employees | 53 (37 on RocketReach) |
| Address | 155 Jefferson Dr Suite 100, Menlo Park, California 94025, US |
| Industry | Medical Equipment Manufacturing |
| Keywords | Endovascular Therapies, Endovascular Devices, Endovascular Procedures, Catheter Technology, Minimally Invasive Surgery, Precision Medicine, Medical Devices, Medical Technology, Vascular Access, Vascular Surgery, Interventional Cardiology, Surgical Instruments, Heart Disease Treatment, Peripheral Vascular Disease, Vascular Stents, Thrombectomy Devices |
| Competitors | Cook Medical, Boston Scientific, Stryker, Cardinal Health, BD, Medtronic, Abbott, AngioDynamics, Cordis, Terumo Heart, Inc. +37 more (view full list) |
Looking for a particular Jupiter Endovascular employee's phone or email?
Carl st. Bernard is the CEO of Jupiter Endovascular.
37 people are employed at Jupiter Endovascular.
Jupiter Endovascular is based in Menlo Park, California.